- Report
- October 2024
- 186 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- December 2024
- 150 Pages
Global
From €4414EUR$4,850USD£3,784GBP
- Report
- February 2025
- 449 Pages
Global
From €4505EUR$4,950USD£3,862GBP
- Report
- October 2024
- 200 Pages
Global
From €2266EUR$2,490USD£1,943GBP
- Report
- March 2025
- 192 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- October 2024
- 194 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- April 2025
- 196 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- April 2025
- 146 Pages
Global
From €2729EUR$2,999USD£2,340GBP
- Report
- August 2024
- 135 Pages
Global
From €2729EUR$2,999USD£2,340GBP
- Report
- July 2024
- 149 Pages
Global
From €2729EUR$2,999USD£2,340GBP
- Report
- April 2025
- 159 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- February 2025
- 223 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- July 2024
- 144 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- October 2024
- 145 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- April 2024
- 180 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- May 2024
- 180 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- July 2024
- 150 Pages
Global
From €3413EUR$3,750USD£2,926GBP
- Report
- November 2024
Global
From €6826EUR$7,500USD£5,852GBP

The Viral Infection market within the context of Infectious Disease Testing is a rapidly growing sector of the healthcare industry. It is focused on the development of tests that can detect the presence of viruses in a patient's body. These tests are used to diagnose and monitor the progression of viral infections, such as influenza, HIV, and hepatitis. They can also be used to detect the presence of other infectious agents, such as bacteria and fungi.
The Viral Infection market is driven by the increasing prevalence of viral infections, as well as the need for more accurate and timely diagnosis. The development of new technologies, such as next-generation sequencing and PCR-based assays, has enabled the development of more sensitive and specific tests. This has led to the emergence of a number of companies offering a range of tests for the detection of viral infections.
Some of the major companies in the Viral Infection market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. These companies offer a range of tests for the detection of viral infections, including PCR-based assays, ELISA-based assays, and next-generation sequencing-based assays. Show Less Read more